Correlation Between BioAffinity Technologies and Helius Medical

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Helius Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Helius Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies Warrant and Helius Medical Technologies, you can compare the effects of market volatilities on BioAffinity Technologies and Helius Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Helius Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Helius Medical.

Diversification Opportunities for BioAffinity Technologies and Helius Medical

-0.45

Correlation Coefficient

BioAffinity Technologies  Helius Medical

Very good diversification

The 3 months correlation between BioAffinity and Helius is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Helius Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helius Medical Techn and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Helius Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helius Medical Techn has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Helius Medical go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Helius Medical

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to under-perform the Helius Medical. But the stock apears to be less risky and, when comparing its historical volatility, bioAffinity Technologies Warrant is 1.53 times less risky than Helius Medical. The stock trades about -0.15 of its potential returns per unit of risk. The Helius Medical Technologies is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  66.00  in Helius Medical Technologies on October 4, 2024 and sell it today you would earn a total of  1.00  from holding Helius Medical Technologies or generate 1.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	66.67%
Values	Daily Returns

bioAffinity Technologies Warra  vs.  Helius Medical Technologies

BioAffinity Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days bioAffinity Technologies Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Helius Medical Techn

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Helius Medical Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Helius Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioAffinity Technologies and Helius Medical

The main advantage of trading using opposite BioAffinity Technologies and Helius Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Helius Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helius Medical will offset losses from the drop in Helius Medical's long position.

The idea behind bioAffinity Technologies Warrant and Helius Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.